Literature DB >> 16046392

Domains and maturation processes that regulate the activity of ADAMTS-2, a metalloproteinase cleaving the aminopropeptide of fibrillar procollagens types I-III and V.

Alain Colige1, Florence Ruggiero, Isabel Vandenberghe, Johanne Dubail, Frederic Kesteloot, Jozef Van Beeumen, Alain Beschin, Lea Brys, Charles M Lapière, Betty Nusgens.   

Abstract

Processing of fibrillar collagens is required to generate collagen monomers able to self-assemble into elongated and cylindrical collagen fibrils. ADAMTS-2 belongs to the "A disintegrin and metalloproteinase with thrombospondin type 1 motifs" (ADAMTS) family. It is responsible for most of the processing of the aminopropeptide of type I procollagen in the skin, and it also cleaves type II and type III procollagens. ADAMTS are complex secreted enzymes that are implicated in various physiological and pathological processes. Despite accumulating evidence indicating that their activity is regulated by ancillary domains, additional information is required for a better understanding of the specific function of each domain. We have generated 17 different recombinant forms of bovine ADAMTS-2 and characterized their processing, activity, and cleavage specificity. The results indicated the following: (i) activation of the ADAMTS-2 zymogen involves several cleavages, by proprotein convertases and C-terminal processing, and generates at least seven distinct processed forms; (ii) the C-terminal domain negatively regulates enzyme activity, whereas two thrombospondin type 1 repeats are enhancer regulators; (iii) the 104-kDa form displays the highest aminoprocollagen peptidase activity on procollagen type I; (iv) ADAMTS-2 processes the aminopropeptide of alpha1 type V procollagen homotrimer at the end of the variable domain; and (v) the cleaved sequence (PA) is different from the previously described sites ((P/A)Q) for ADAMTS-2, redefining its cleavage specificity. This finding and the existence of multiple processed forms of ADAMTS-2 strongly suggest that ADAMTS-2 may be involved in function(s) other than processing of fibrillar procollagen types I-III.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16046392     DOI: 10.1074/jbc.M506458200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Disruption of the developmentally-regulated Col2a1 pre-mRNA alternative splicing switch in a transgenic knock-in mouse model.

Authors:  Renate Lewis; Soumya Ravindran; Louisa Wirthlin; Geoffrey Traeger; Russell J Fernandes; Audrey McAlinden
Journal:  Matrix Biol       Date:  2012-01-09       Impact factor: 11.583

2.  ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity.

Authors:  J Dubail; F Kesteloot; C Deroanne; P Motte; V Lambert; J-M Rakic; C Lapière; B Nusgens; A Colige
Journal:  Cell Mol Life Sci       Date:  2010-06-24       Impact factor: 9.261

3.  A bioresponsive hydrogel tuned to chondrogenesis of human mesenchymal stem cells.

Authors:  Chelsea S Bahney; Chih-Wei Hsu; Jung U Yoo; Jennifer L West; Brian Johnstone
Journal:  FASEB J       Date:  2011-01-31       Impact factor: 5.191

4.  Tissue-specific induction of ADAMTS2 in monocytes and macrophages by glucocorticoids.

Authors:  Thomas P J Hofer; Marion Frankenberger; Jörg Mages; Roland Lang; Peter Meyer; Reinhard Hoffmann; Alain Colige; Löms Ziegler-Heitbrock
Journal:  J Mol Med (Berl)       Date:  2007-12-14       Impact factor: 4.599

Review 5.  A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms.

Authors:  Suneel S Apte
Journal:  J Biol Chem       Date:  2009-09-04       Impact factor: 5.157

6.  Differential cleavage of lysyl oxidase by the metalloproteinases BMP1 and ADAMTS2/14 regulates collagen binding through a tyrosine sulfate domain.

Authors:  Tamara Rosell-García; Alberto Paradela; Gema Bravo; Laura Dupont; Mourad Bekhouche; Alain Colige; Fernando Rodriguez-Pascual
Journal:  J Biol Chem       Date:  2019-05-31       Impact factor: 5.157

Review 7.  The roles of ADAMTS in angiogenesis and cancer.

Authors:  Yi Sun; Jintuan Huang; Zuli Yang
Journal:  Tumour Biol       Date:  2015-04-28

Review 8.  Anti-ADAMTS5 monoclonal antibodies: implications for aggrecanase inhibition in osteoarthritis.

Authors:  Suneel S Apte
Journal:  Biochem J       Date:  2016-01-01       Impact factor: 3.857

9.  Role of the netrin-like domain of procollagen C-proteinase enhancer-1 in the control of metalloproteinase activity.

Authors:  Mourad Bekhouche; Daniel Kronenberg; Sandrine Vadon-Le Goff; Cécile Bijakowski; Ngee Han Lim; Bernard Font; Efrat Kessler; Alain Colige; Hideaki Nagase; Gillian Murphy; David J S Hulmes; Catherine Moali
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

Review 10.  Role of ADAM and ADAMTS metalloproteinases in airway diseases.

Authors:  Genevieve Paulissen; Natacha Rocks; Maud M Gueders; Celine Crahay; Florence Quesada-Calvo; Sandrine Bekaert; Jonathan Hacha; Mehdi El Hour; Jean-Michel Foidart; Agnes Noel; Didier D Cataldo
Journal:  Respir Res       Date:  2009-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.